Erschienen in:
Respiration, 95 (2018) Suppl. 1, Seite 3-5
Sprache:
Englisch
DOI:
10.1159/000487169
ISSN:
1423-0356;
0025-7931
Entstehung:
Anmerkungen:
Beschreibung:
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, and it is associated with a high economic burden. Heart failure shares some general symptoms with COPD; thus, diagnosing COPD is difficult in subjects with a history of heart failure, and spirometry is mandatory for confirmation. Moreover, COPD is a highly prevalent comorbidity negatively impacting the outcome of heart failure patients. We document here the treatment with indacaterol/glycopyrronium in 2 patients with concomitant COPD and heart failure. Overall, the combination of indacaterol and glycopyrronium resulted in a reciprocal potentiation with a maximal bronchodilatory effect.